Managed Care
Disease
Management

HCFA: Medicaid Must Now Cover Growth Hormone

MANAGED CARE May 1999. © MediMedia USA
News and Commentary

HCFA: Medicaid Must Now Cover Growth Hormone

MANAGED CARE May 1999. ©1999 Stezzi Communications

The Health Care Financing Administration has ordered Medicaid to cover Serostim, a growth hormone that can stifle cachexia — also known to AIDS patients as wasting.... Two New York representatives have introduced a measure in Congress that would require health plans to cover routine breast, cervical, colorectal, and prostate cancer screenings under Medicare's screening-benefit schedule.... Florida legislators were to consider compromise legislation in late April mandating coverage of bone-marrow transplants, autism-spectrum disease, and oral contraceptives, all of which would add $40 million to costs, HMOs say.... The California legislature is considering a similar bill regarding coverage of oral contraceptives.... Meanwhile, California officials have told Health Net not to cut 14 drugs from its formulary, including Prozac and two drugs for cystic fibrosis that patient groups say have no adequate substitutes.

Meetings

HealthIMPACT Southeast Tampa, FL January 23, 2015

Our other journal

P&T Journal for November 2014

Features

LETTER TO THE EDITOR

Medications for Parkinson’s Disease

PERSPECTIVE

The Changing Roles of P&T Committees

Epilepsy Management: Newer Agents, Unmet Needs, and Future Treatment Strategies

PIPELINE PLUS

Modest Growth Seen in Epilepsy Market

MEETING HIGHLIGHTS

European Society of Cardiology and Transcatheter Cardiovascular Therapeutics

BOOK REVIEW

“Generic: The Unbranding of Modern Medicine,” by Jeremy A. Greene, MD, PhD

DEPARTMENTS

MEDICATION ERRORS

Misadministration of IV Insulin Associated With Dose Measurement And Hyperkalemia Treatment

PRESCRIPTION: WASHINGTON

FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds

New Drugs/Drug News

Pharmaceutical Approval Update

DRUG FORECAST

Riociguat (Adempas): a Novel Agent For the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension